General Motors Co (GM) Stock News

Monteverde & Associates PC is investigating four merger and acquisition transactions on behalf of shareholders. Pacific Financial Corporation is merging with Banner Corporation (0.2633 shares per share), Nuvalent Inc. is being acquired by GSK plc ($124.00 per share), Cross Country Healthcare is being sold to KL Criss Cross Intermediate LLC ($13.25 per share), and Bio Green Med Solution is merging with Future NRG Sdn. Bhd. Shareholders are encouraged to contact the firm regarding potential concerns with these transactions.

Entrée Resources Ltd. held its annual general meeting on June 18, 2026, where shareholders approved all matters including setting the board at seven directors. Richard Williams, a mining executive with 35+ years of experience, was elected to the board. The company also renewed its Stock Option Plan and re-appointed Davidson & Company LLP as auditors.

New York, NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Admaxxer , a direct-to-consumer (DTC) analytics and AI ad-operations platform for Shopify and other e-commerce brands, today reported four operating milestones, measured as of May 31, 2026, and reinforced its positioning as the leading Triple Whale alternative for DTC Shopify analytics, per the company's platform metrics update (published at https://admaxxer.com/methodology ): 12,000 active brands on the platform — workspaces with at least one connected ad-platform account and at least one tracked event in the trailing 30 days, as of May 31, 2026. $3 billion in cumulative tracked gross merchandise value (GMV) — purchase-event revenue ingested through Admaxxer's first-party analytics pixel since platform launch. 93% average Conversions API (CAPI) match rate — measured across more than 15 million tracked events processed and forwarded to Meta's Conversions API during April–May 2026, using Meta's matched-event response as the reference baseline. Launch of a reconciled multi-touch attribution model and an expanded Model Context Protocol (MCP) server — the attribution model resolves multi-touch attribution, media-mix modeling, incrementality, and post-purchase survey signal into a single "Total Impact" figure over a 90-day lookback window; the MCP server now exposes eleven tools to external AI clients. Why Brands Choose Admaxxer as a Triple Whale Alternative Admaxxer is a direct-to-consumer analytics and ad-operations platform that brands adopt as an alternative to Triple Whale. It operates in the same category as Triple Whale and a number of attribution-focused and media-mix-modeling vendors, and differentiates on five capabilities: Bring-your-own-key (BYOK) AI across 10 large-language-model providers. Operators connect their own AI subscription — OpenAI, Anthropic, Google (Gemini), xAI (Grok), DeepSeek, Mistral, Perpl

General Motors and Ford are both entering the battery energy storage systems market. GM's partnership with Peak Energy to develop sodium-ion batteries offers potential cost advantages over lithium-iron phosphate alternatives, with potential 20% cost reductions and no cooling system requirements. Both automakers are targeting significant deployment capacity, with Ford aiming for 20 GWh annually by late 2027. Tesla Energy demonstrates the market's profitability, generating $12.7 billion in revenue with ~30% margins.

General Motors is entering the battery storage business alongside Ford, intensifying competition in a market previously dominated by Tesla. This expansion represents a significant shift in the automotive industry's approach to energy storage solutions.

The article compares two global stock ETFs: SPGM (State Street SPDR Portfolio MSCI Global Stock Market ETF) and IEFA (iShares Core MSCI EAFE ETF). SPGM offers broader global exposure including U.S. and emerging markets with superior 5-year returns (28.04% vs 21.55%), while IEFA focuses on developed international markets with a lower expense ratio (0.07% vs 0.09%) and higher dividend yield (3.24% vs 1.67%). The recommendation favors IEFA for investors already holding U.S. equities, citing better diversification and income potential.

Profusa has submitted a comprehensive response package to its European Notified Body GMED following successful completion of Stage 1 and Stage 2 assessments for CE Mark certification of its Lumee Oxygen Platform. The submission includes updates to technical documentation, quality system evidence, clinical evaluation activities, and validation information. The company remains committed to obtaining CE Mark certification to support European commercialization of its tissue oxygen monitoring technology.

JSC Kaspi.kz held an Extraordinary General Meeting on June 11, 2026, where shareholders approved a dividend payment of KZT 850 per common share for Q1 2026. The company also appointed three members to its Counting commission with unlimited terms of power.

Cosmos Health Inc. (NASDAQ: COSM) announced a non-binding letter of intent to acquire 100% of Doc Pharma S.A., a European GMP-licensed pharmaceutical manufacturer. The acquisition is expected to be immediately accretive, expanding Cosmos Health's asset base by approximately $24 million, adding $6.7 million in average annual revenue and $3.2 million in gross profit. The deal aims to deepen vertical integration, improve margins, expand production capacity, and strengthen the company's R&D capabilities. The transaction is subject to independent director review, fairness opinion, and shareholder approval.

Anteris Technologies announced it has received full regulatory clearance from France's ANSM to conduct the PARADIGM Trial for its DurAVR® Transcatheter Heart Valve. The prospective randomized controlled trial will enroll approximately 1,000 patients to evaluate the safety and effectiveness of DurAVR® compared to commercially available TAVR devices, with patient recruitment now commencing at leading French centers.

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="center">PRESS RELEASE</p> <p align="right"><i>Bloomberg (THEON:NA) / Reuters (THEON.AS)</i></p> <p align="right"><i><br /></i></p> <p align="justify">04 June 2026 –<b> </b><a href="https://www.globenewswire.com/Tracker?data=5BaoGwV3ZJ_J-v1UTLPNyLeazFSX-rXYIS9Y2uCjr-X8B_dFV9JJwV_44vAT4lCvS8rNBIl4o3Kz5Ca2M2eKIvsJwVWZWd7pJ8KVteVuQzS1ZTfyrA-3PxGGBHEuQR_6nVIMfwGnQTALk4pcsjAfYtKIn_vqNuIbPZot-VHnA6qdGuRly06ShvyCrA3TVJGCYeBbfIspQe1nqlPRB03hYUkofTqv5tlmaF5omQKowt5txZFfL8WUOtdk7uu2GFXYlCLkftFmrg2H646M9BiNyfapz0i45MB1zqaio57OGeyQUCOcI2ogvu38Invfr4QKUW2S0ds04s1AmvDW1XprRZcrrV5azcDVQL5k2e1lLZvvmnDzANlQf0ZOkH2iuGhbmCamkzxtBqHHWawHdtYphV2GXjt7_lLcdGlt4MlvjQm_igiqWWOgsM7DHsvCKFDqIQUFFaXtSbSLlLuOfIk9et_Xq9y_6asmef3Fn9iACus=" rel="nofollow" target="_blank" rel="nofollow">Theon International Plc (THEON)</a> announces that its AGM held earlier today all resolutions were approved and agenda items adopted, including the declaration of dividends for the year 2025 as given below:</p> <p><i>Total Amount:</i> €24,373,639.95<br /><i>Amount per Share:</i> €0.31 per share<br /><i>Ex-dividend Date:</i> 18 June 2026<br /><i>Record Date:</i> 19 June 2026<br /><i>Payment Date:</i> 26 June 2026</p> <p>For payment details and more information, you may contact Coöperatieve Rabobank U.A at <a href="https://www.globenewswire.com/Tracker?data=emxgMFjH6UP4IyNQEsvLHVKE_OD0ZOUcC99cKjl8LZM1xtSmdQ28VQsseoXdjEvu_jVJtkRV2JTK1cZDz8Z_LoZyRXpe25vj2lQqItNb5-EaxBd2OSexLVCusWwRozmWdUqMEmi_0

Capital Link has launched Capital Link Shipping, a free maritime intelligence platform featuring exclusive discussions with senior executives from major shipping companies including Star Bulk Carriers, Heidmar Maritime Holdings, and GMS. The platform provides market intelligence, shipping data, expert insights, and industry analysis across dry bulk, tanker, container, and gas shipping sectors.

MGM Resorts and Caesars Entertainment are compared as investment options in the casino industry. MGM focuses on luxury destinations with global expansion, particularly in Macao, while Caesars operates 52 domestic properties with a strong loyalty program. MGM shows better financial health with lower debt and higher profitability, though both companies face potential acquisition offers that could affect their public market availability.

IAC's $48.30 per share non-binding offer for MGM Resorts International triggered a 16% stock surge, with shares trading above the bid price at $50.69. This negative arbitrage spread signals market skepticism about the lowball offer and expectations for a higher bid. The move reflects broader consolidation in gaming, following Tilman Fertitta's $17.6 billion Caesars Entertainment acquisition, driven by investor interest in casino real estate assets and digital gaming platforms like BetMGM.

MGM Resorts received a non-binding buyout offer of $48.30 per share from People Incorporated (formerly IAC), causing the stock to surge 16%. However, shares are trading above the offer price as investors anticipate higher valuations. The analyst notes the offer lacks current financing and suggests MGM may unlock more value as an independent company long-term.

MGM Resorts International stock surged 15% on Monday after People Inc. (formerly IAC Inc.) proposed acquiring the casino operator's remaining shares for $48.30 per share in cash, representing a 24.1% premium to the 30-day volume-weighted average price. Barry Diller's People Inc., which already owns 26.1% of MGM, believes the company is undervalued and plans to finance the transaction using cash, debt, and equity commitments. The stock has rallied significantly above its moving averages, though technical indicators suggest potential overbought conditions.

Barry Diller's People Inc. is preparing a bid for MGM Resorts at $48.30 per share.

MGM Resorts International (NYSE: MGM ) stock surged 15% on Monday after People Incorporated , formerly IAC Inc. (NASDAQ: IAC ) , proposed acquiring the casino operator’s remaining outstanding shares for $48.30 apiece in cash, a bid that would take MGM private and values the offer at a significant premium to recent trading levels . The non-binding proposal values MGM shares at a 24.1% premium to their 30-day volume-weighted average price through May 29, more than a 30% premium to the 90-day average price and a 10.6% premium to the stock’s most recent closing price. People Inc. already owns 26.1% of MGM’s outstanding common stock. Diller Says MGM Is Undervalued “We began investing in MGM nearly six years ago because we believed it represented a rare kind of business: one with real world assets that AI cannot easily replicate or disintermediate and exceptional digital growth opportunities. That conviction has only strengthened over time,” said Barry Diller , chairman and senior executive of People Inc. Diller said the company believes public markets continue to undervalue MGM’s assets and growth potential. He added that the proposal would give shareholders an opportunity to “de-risk their investment and realize immediate, attractive value in cash for their shares.” Financing Plan Outlined People Inc. said it expects to finance the transaction using a combination of cash on hand at both companies ... Full story available on Benzinga.com

AGM Group Holdings (AGMH) received a deficiency notice from Nasdaq on May 18, 2026, for failing to file its Form 20-F annual report for fiscal year 2025 on time. This marks the third consecutive year the company has missed its annual filing deadline, raising concerns about systemic issues in its reporting process. While not an immediate delisting threat, the pattern suggests deteriorating investor confidence in the company's financial transparency and internal controls.

General Motors is investing over $1.3 billion in U.S. manufacturing to boost production capacity for transmissions and next-generation V8 engines for its highly profitable full-size pickups (Silverado and Sierra). Unlike previous EV investments that resulted in massive write-downs, these investments target proven high-margin vehicles with lower uncertainty and stronger near-term profit potential.

Hedge fund GMT Capital Corp. established a new position in Marriott Vacations Worldwide by acquiring 1,023,450 shares worth approximately $66.65 million in Q1 2026, making it the fund's 11th largest holding. The investment reflects bullish sentiment on the company's strong Q1 revenue growth and improved free cash flow forecasts, though the stock's valuation appears elevated and has underperformed the S&P 500 by 22.48 percentage points over the past year.

Avaí Bio and Austrianova announced completion of a GMP Master Cell Bank containing genetically modified cells that overexpress the α-Klotho protein. The MCB will undergo comprehensive viral and contamination testing to meet FDA regulatory standards. Upon successful completion, the companies will generate a Working Cell Bank to manufacture the final Cell-in-a-Box encapsulated clinical product for treating age-related disorders.

The Schwab Emerging Markets Equity ETF (SCHE) offers a lower expense ratio (0.07%) and higher dividend yield (2.60%) compared to State Street's SPDR Portfolio MSCI Global Stock Market ETF (SPGM at 0.09% and 1.70%). However, SPGM has delivered superior 5-year returns ($1,775 vs $1,373 on $1,000 invested) with lower volatility. SCHE focuses exclusively on emerging markets with significant China exposure (31%), while SPGM provides broader global diversification including 62% U.S. exposure, making it better suited as a core portfolio holding.

Ford's F-Series truck inventory has dropped over 40% due to an aluminum factory fire, creating an opportunity for rival GM to gain market share. GM is ramping up production of its Silverado and Sierra trucks to capitalize on Ford's weakness, though GM itself faces inventory challenges and upcoming production downtime for new truck launches later in 2026.

Metalla Royalty & Streaming Ltd. has nominated Sandeep Singh to its board of directors ahead of its annual general meeting scheduled for June 23, 2026. Singh brings two decades of mining and royalty sector experience, including previous roles as CEO of Western Copper and Gold and Osisko Gold Royalties, along with extensive investment banking background in metals and mining.

Silexion Therapeutics has initiated GMP clinical manufacturing of SIL204, its next-generation siRNA therapy targeting mutated KRAS in pancreatic cancer, in collaboration with CDMO Catalent at its Limoges, France facility. The company received approval from Tel Aviv Sourasky Medical Center's Helsinki Ethics Committee for its planned Phase 2/3 trial in locally advanced pancreatic cancer, following earlier approvals from the Israeli Ministry of Health and a clinical trial application submission to Germany's BfArM.

General Motors is laying off hundreds of salaried employees in its information technology operations.